- Reaction score
- 1,727
Both sprays are developed to function by heightening the immune system in a person’s nose.
University of Houston researchers have developed two new nasal sprays for respiratory viruses like the flu and COVID-19.
Dr. Navin Varadarajan is an MD Anderson Professor at the University of Houston. He said one spray is a therapeutic, and the other could be a universal vaccine that prevents transmission for many COVID variants, which are airborne.
"The therapeutic will have a maximum impact on people who are immunocompromised to try and restore their immunity by activating it. Then, they're protected from hospitalization,” he said.
The therapeutic nasal spray would be taken when someone is already showing symptoms, Varadarajan said, like taking Tylenol for a headache.
University of Houston researchers have developed two new nasal sprays for respiratory viruses like the flu and COVID-19.
Dr. Navin Varadarajan is an MD Anderson Professor at the University of Houston. He said one spray is a therapeutic, and the other could be a universal vaccine that prevents transmission for many COVID variants, which are airborne.
"The therapeutic will have a maximum impact on people who are immunocompromised to try and restore their immunity by activating it. Then, they're protected from hospitalization,” he said.
The therapeutic nasal spray would be taken when someone is already showing symptoms, Varadarajan said, like taking Tylenol for a headache.
UH researchers have developed two nasal sprays for respiratory viruses, COVID-19 | Houston Public Media
Both sprays are developed to function by heightening the immune system in a person's nose.
www.houstonpublicmedia.org